nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2E1—liver cancer	0.568	1	CbGaD
Almotriptan—CYP2C8—Sorafenib—liver cancer	0.0484	0.233	CbGbCtD
Almotriptan—CYP2C19—Sorafenib—liver cancer	0.0406	0.196	CbGbCtD
Almotriptan—CYP1A2—Sorafenib—liver cancer	0.0374	0.18	CbGbCtD
Almotriptan—CYP2D6—Sorafenib—liver cancer	0.0308	0.149	CbGbCtD
Almotriptan—CYP3A4—Sorafenib—liver cancer	0.0196	0.0945	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—liver cancer	0.0187	0.0902	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—liver cancer	0.0119	0.0574	CbGbCtD
Almotriptan—Ischaemia—Sorafenib—liver cancer	0.00497	0.0425	CcSEcCtD
Almotriptan—Myocardial ischaemia—Sorafenib—liver cancer	0.00225	0.0193	CcSEcCtD
Almotriptan—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00201	0.0171	CcSEcCtD
Almotriptan—Bone disorder—Sorafenib—liver cancer	0.00201	0.0171	CcSEcCtD
Almotriptan—Hemiplegia—Epirubicin—liver cancer	0.00188	0.016	CcSEcCtD
Almotriptan—Hemiplegia—Doxorubicin—liver cancer	0.00174	0.0148	CcSEcCtD
Almotriptan—Neuropathy—Sorafenib—liver cancer	0.0017	0.0145	CcSEcCtD
Almotriptan—Pain in extremity—Sorafenib—liver cancer	0.00132	0.0112	CcSEcCtD
Almotriptan—Abdominal pain upper—Sorafenib—liver cancer	0.0012	0.0103	CcSEcCtD
Almotriptan—Breast disorder—Sorafenib—liver cancer	0.00119	0.0102	CcSEcCtD
Almotriptan—Gastritis—Sorafenib—liver cancer	0.00116	0.00995	CcSEcCtD
Almotriptan—Abdominal discomfort—Sorafenib—liver cancer	0.00109	0.00932	CcSEcCtD
Almotriptan—Parosmia—Epirubicin—liver cancer	0.00103	0.00883	CcSEcCtD
Almotriptan—Acute coronary syndrome—Sorafenib—liver cancer	0.001	0.00854	CcSEcCtD
Almotriptan—Myocardial infarction—Sorafenib—liver cancer	0.000994	0.00849	CcSEcCtD
Almotriptan—Neuropathy peripheral—Sorafenib—liver cancer	0.000994	0.00849	CcSEcCtD
Almotriptan—Hyperventilation—Epirubicin—liver cancer	0.000973	0.00832	CcSEcCtD
Almotriptan—Epistaxis—Sorafenib—liver cancer	0.000956	0.00817	CcSEcCtD
Almotriptan—Parosmia—Doxorubicin—liver cancer	0.000956	0.00817	CcSEcCtD
Almotriptan—Nystagmus—Epirubicin—liver cancer	0.000938	0.00801	CcSEcCtD
Almotriptan—Laryngitis—Epirubicin—liver cancer	0.000929	0.00794	CcSEcCtD
Almotriptan—Hyperventilation—Doxorubicin—liver cancer	0.000901	0.0077	CcSEcCtD
Almotriptan—Scotoma—Epirubicin—liver cancer	0.000882	0.00754	CcSEcCtD
Almotriptan—Nystagmus—Doxorubicin—liver cancer	0.000868	0.00742	CcSEcCtD
Almotriptan—Otitis media—Epirubicin—liver cancer	0.00086	0.00735	CcSEcCtD
Almotriptan—Laryngitis—Doxorubicin—liver cancer	0.00086	0.00735	CcSEcCtD
Almotriptan—Tinnitus—Sorafenib—liver cancer	0.000849	0.00725	CcSEcCtD
Almotriptan—Cardiac disorder—Sorafenib—liver cancer	0.000845	0.00722	CcSEcCtD
Almotriptan—Immune system disorder—Sorafenib—liver cancer	0.000822	0.00703	CcSEcCtD
Almotriptan—Scotoma—Doxorubicin—liver cancer	0.000816	0.00698	CcSEcCtD
Almotriptan—Mental disorder—Sorafenib—liver cancer	0.000797	0.00682	CcSEcCtD
Almotriptan—Otitis media—Doxorubicin—liver cancer	0.000796	0.0068	CcSEcCtD
Almotriptan—Erythema—Sorafenib—liver cancer	0.000792	0.00677	CcSEcCtD
Almotriptan—Dysgeusia—Sorafenib—liver cancer	0.000776	0.00663	CcSEcCtD
Almotriptan—Breast pain—Epirubicin—liver cancer	0.000768	0.00656	CcSEcCtD
Almotriptan—Vasodilation procedure—Epirubicin—liver cancer	0.000762	0.00652	CcSEcCtD
Almotriptan—Vasodilation—Epirubicin—liver cancer	0.000762	0.00652	CcSEcCtD
Almotriptan—Bone disorder—Epirubicin—liver cancer	0.000742	0.00634	CcSEcCtD
Almotriptan—Angioedema—Sorafenib—liver cancer	0.000724	0.00619	CcSEcCtD
Almotriptan—Syncope—Sorafenib—liver cancer	0.000711	0.00607	CcSEcCtD
Almotriptan—Breast pain—Doxorubicin—liver cancer	0.00071	0.00607	CcSEcCtD
Almotriptan—Vasodilation—Doxorubicin—liver cancer	0.000705	0.00603	CcSEcCtD
Almotriptan—Vasodilation procedure—Doxorubicin—liver cancer	0.000705	0.00603	CcSEcCtD
Almotriptan—Loss of consciousness—Sorafenib—liver cancer	0.000696	0.00595	CcSEcCtD
Almotriptan—Bone disorder—Doxorubicin—liver cancer	0.000686	0.00586	CcSEcCtD
Almotriptan—Hypertension—Sorafenib—liver cancer	0.000684	0.00585	CcSEcCtD
Almotriptan—Coordination abnormal—Epirubicin—liver cancer	0.000682	0.00583	CcSEcCtD
Almotriptan—Neck pain—Epirubicin—liver cancer	0.000678	0.00579	CcSEcCtD
Almotriptan—Arthralgia—Sorafenib—liver cancer	0.000675	0.00577	CcSEcCtD
Almotriptan—Myalgia—Sorafenib—liver cancer	0.000675	0.00577	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00067	0.00573	CcSEcCtD
Almotriptan—Ventricular tachycardia—Epirubicin—liver cancer	0.00067	0.00573	CcSEcCtD
Almotriptan—Dry mouth—Sorafenib—liver cancer	0.00066	0.00564	CcSEcCtD
Almotriptan—Salivary hypersecretion—Epirubicin—liver cancer	0.000651	0.00556	CcSEcCtD
Almotriptan—Anaphylactic shock—Sorafenib—liver cancer	0.000647	0.00553	CcSEcCtD
Almotriptan—Colitis—Epirubicin—liver cancer	0.000643	0.0055	CcSEcCtD
Almotriptan—Shock—Sorafenib—liver cancer	0.000636	0.00544	CcSEcCtD
Almotriptan—Nervous system disorder—Sorafenib—liver cancer	0.000634	0.00542	CcSEcCtD
Almotriptan—Coordination abnormal—Doxorubicin—liver cancer	0.000631	0.00539	CcSEcCtD
Almotriptan—Neuropathy—Epirubicin—liver cancer	0.000629	0.00537	CcSEcCtD
Almotriptan—Skin disorder—Sorafenib—liver cancer	0.000628	0.00537	CcSEcCtD
Almotriptan—Neck pain—Doxorubicin—liver cancer	0.000627	0.00536	CcSEcCtD
Almotriptan—Ventricular tachycardia—Doxorubicin—liver cancer	0.00062	0.0053	CcSEcCtD
Almotriptan—Dry eye—Epirubicin—liver cancer	0.000619	0.00529	CcSEcCtD
Almotriptan—Salivary hypersecretion—Doxorubicin—liver cancer	0.000602	0.00514	CcSEcCtD
Almotriptan—Colitis—Doxorubicin—liver cancer	0.000595	0.00509	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000589	0.00504	CcSEcCtD
Almotriptan—Hypertonia—Epirubicin—liver cancer	0.000587	0.00502	CcSEcCtD
Almotriptan—Neuropathy—Doxorubicin—liver cancer	0.000582	0.00497	CcSEcCtD
Almotriptan—Mental disability—Epirubicin—liver cancer	0.000581	0.00497	CcSEcCtD
Almotriptan—Dyspnoea—Sorafenib—liver cancer	0.000577	0.00493	CcSEcCtD
Almotriptan—Dry eye—Doxorubicin—liver cancer	0.000572	0.00489	CcSEcCtD
Almotriptan—Dyspepsia—Sorafenib—liver cancer	0.000569	0.00486	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Sorafenib—liver cancer	0.000558	0.00477	CcSEcCtD
Almotriptan—Melatonin—ESR1—liver cancer	0.000558	0.556	CrCbGaD
Almotriptan—Fatigue—Sorafenib—liver cancer	0.000558	0.00476	CcSEcCtD
Almotriptan—Pain—Sorafenib—liver cancer	0.000553	0.00473	CcSEcCtD
Almotriptan—Hypertonia—Doxorubicin—liver cancer	0.000543	0.00464	CcSEcCtD
Almotriptan—Eye pain—Epirubicin—liver cancer	0.000539	0.0046	CcSEcCtD
Almotriptan—Mental disability—Doxorubicin—liver cancer	0.000538	0.0046	CcSEcCtD
Almotriptan—Gastrointestinal pain—Sorafenib—liver cancer	0.000529	0.00452	CcSEcCtD
Almotriptan—Body temperature increased—Sorafenib—liver cancer	0.000511	0.00437	CcSEcCtD
Almotriptan—Abdominal pain—Sorafenib—liver cancer	0.000511	0.00437	CcSEcCtD
Almotriptan—Eye pain—Doxorubicin—liver cancer	0.000498	0.00426	CcSEcCtD
Almotriptan—Pain in extremity—Epirubicin—liver cancer	0.000486	0.00416	CcSEcCtD
Almotriptan—Diplopia—Epirubicin—liver cancer	0.000486	0.00416	CcSEcCtD
Almotriptan—Hypersensitivity—Sorafenib—liver cancer	0.000476	0.00407	CcSEcCtD
Almotriptan—Asthenia—Sorafenib—liver cancer	0.000464	0.00397	CcSEcCtD
Almotriptan—Pruritus—Sorafenib—liver cancer	0.000458	0.00391	CcSEcCtD
Almotriptan—Diplopia—Doxorubicin—liver cancer	0.00045	0.00385	CcSEcCtD
Almotriptan—Pain in extremity—Doxorubicin—liver cancer	0.00045	0.00385	CcSEcCtD
Almotriptan—Melatonin—CYP1A1—liver cancer	0.000446	0.444	CrCbGaD
Almotriptan—Abdominal pain upper—Epirubicin—liver cancer	0.000444	0.0038	CcSEcCtD
Almotriptan—Diarrhoea—Sorafenib—liver cancer	0.000442	0.00378	CcSEcCtD
Almotriptan—Breast disorder—Epirubicin—liver cancer	0.000439	0.00376	CcSEcCtD
Almotriptan—Gastritis—Epirubicin—liver cancer	0.00043	0.00368	CcSEcCtD
Almotriptan—Muscular weakness—Epirubicin—liver cancer	0.000429	0.00367	CcSEcCtD
Almotriptan—Dizziness—Sorafenib—liver cancer	0.000428	0.00365	CcSEcCtD
Almotriptan—Vomiting—Sorafenib—liver cancer	0.000411	0.00351	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—liver cancer	0.000411	0.00351	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—liver cancer	0.000409	0.0035	CcSEcCtD
Almotriptan—Rash—Sorafenib—liver cancer	0.000408	0.00348	CcSEcCtD
Almotriptan—Dermatitis—Sorafenib—liver cancer	0.000407	0.00348	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—liver cancer	0.000407	0.00347	CcSEcCtD
Almotriptan—Headache—Sorafenib—liver cancer	0.000405	0.00346	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—liver cancer	0.000404	0.00345	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—liver cancer	0.000398	0.0034	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—liver cancer	0.000397	0.00339	CcSEcCtD
Almotriptan—Nausea—Sorafenib—liver cancer	0.000384	0.00328	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—liver cancer	0.000384	0.00328	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—liver cancer	0.000379	0.00324	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—liver cancer	0.000379	0.00324	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—liver cancer	0.000374	0.0032	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—liver cancer	0.000367	0.00314	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—liver cancer	0.000364	0.00311	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—liver cancer	0.000355	0.00303	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—liver cancer	0.000353	0.00302	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—liver cancer	0.000352	0.003	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—liver cancer	0.000351	0.003	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—liver cancer	0.00034	0.0029	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—liver cancer	0.000337	0.00288	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—liver cancer	0.000337	0.00288	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—liver cancer	0.000335	0.00286	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—liver cancer	0.000334	0.00285	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—liver cancer	0.000327	0.00279	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—liver cancer	0.000325	0.00278	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—liver cancer	0.000324	0.00277	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—liver cancer	0.000314	0.00269	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—liver cancer	0.000314	0.00268	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—liver cancer	0.000312	0.00267	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—liver cancer	0.000312	0.00267	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—liver cancer	0.00031	0.00265	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—liver cancer	0.000309	0.00264	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—liver cancer	0.000304	0.0026	CcSEcCtD
Almotriptan—Chills—Epirubicin—liver cancer	0.000302	0.00258	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—liver cancer	0.0003	0.00256	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—liver cancer	0.000295	0.00252	CcSEcCtD
Almotriptan—Erythema—Epirubicin—liver cancer	0.000293	0.0025	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—liver cancer	0.000291	0.00249	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—liver cancer	0.00029	0.00248	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—liver cancer	0.000289	0.00247	CcSEcCtD
Almotriptan—Tension—Epirubicin—liver cancer	0.000287	0.00246	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—liver cancer	0.000287	0.00245	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—liver cancer	0.000284	0.00243	CcSEcCtD
Almotriptan—Back pain—Epirubicin—liver cancer	0.000283	0.00242	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—liver cancer	0.000281	0.0024	CcSEcCtD
Almotriptan—Chills—Doxorubicin—liver cancer	0.000279	0.00239	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—liver cancer	0.000276	0.00236	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—liver cancer	0.000273	0.00233	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—liver cancer	0.000272	0.00232	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—liver cancer	0.000271	0.00232	CcSEcCtD
Almotriptan—Agitation—Epirubicin—liver cancer	0.000269	0.0023	CcSEcCtD
Almotriptan—Tension—Doxorubicin—liver cancer	0.000266	0.00227	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—liver cancer	0.000265	0.00227	CcSEcCtD
Almotriptan—Malaise—Epirubicin—liver cancer	0.000264	0.00226	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—liver cancer	0.000263	0.00225	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—liver cancer	0.000263	0.00225	CcSEcCtD
Almotriptan—Syncope—Epirubicin—liver cancer	0.000263	0.00224	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—liver cancer	0.000262	0.00224	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—liver cancer	0.000259	0.00221	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—liver cancer	0.000257	0.0022	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—liver cancer	0.000255	0.00218	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—liver cancer	0.000254	0.00217	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—liver cancer	0.000253	0.00216	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—liver cancer	0.000251	0.00215	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—liver cancer	0.000249	0.00213	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—liver cancer	0.000249	0.00213	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—liver cancer	0.000249	0.00213	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—liver cancer	0.000249	0.00213	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—liver cancer	0.000248	0.00212	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000248	0.00212	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—liver cancer	0.000246	0.00211	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—liver cancer	0.000244	0.00209	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—liver cancer	0.000244	0.00208	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—liver cancer	0.000243	0.00208	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—liver cancer	0.000243	0.00208	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—liver cancer	0.000241	0.00206	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—liver cancer	0.000239	0.00205	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—liver cancer	0.000239	0.00204	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—liver cancer	0.000238	0.00204	CcSEcCtD
Almotriptan—Shock—Epirubicin—liver cancer	0.000235	0.00201	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—liver cancer	0.000235	0.00201	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—liver cancer	0.000234	0.002	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—liver cancer	0.000234	0.002	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—liver cancer	0.000233	0.00199	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—liver cancer	0.000232	0.00198	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—liver cancer	0.000231	0.00197	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—liver cancer	0.000231	0.00197	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—liver cancer	0.000231	0.00197	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—liver cancer	0.000231	0.00197	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—liver cancer	0.00023	0.00196	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000229	0.00196	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—liver cancer	0.000228	0.00195	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—liver cancer	0.000226	0.00193	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—liver cancer	0.000223	0.00191	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—liver cancer	0.000221	0.00189	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000218	0.00186	CcSEcCtD
Almotriptan—Shock—Doxorubicin—liver cancer	0.000218	0.00186	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—liver cancer	0.000217	0.00185	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—liver cancer	0.000216	0.00185	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—liver cancer	0.000216	0.00184	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—liver cancer	0.000215	0.00184	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—liver cancer	0.000215	0.00183	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—liver cancer	0.000214	0.00183	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—liver cancer	0.000213	0.00182	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—liver cancer	0.000212	0.00182	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—liver cancer	0.00021	0.0018	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000206	0.00176	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—liver cancer	0.000206	0.00176	CcSEcCtD
Almotriptan—Pain—Epirubicin—liver cancer	0.000204	0.00175	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000201	0.00172	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—liver cancer	0.0002	0.00171	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—liver cancer	0.000199	0.0017	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—liver cancer	0.000197	0.00168	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—liver cancer	0.000197	0.00168	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—liver cancer	0.000197	0.00168	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—liver cancer	0.000195	0.00167	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—liver cancer	0.000195	0.00166	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000191	0.00163	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—liver cancer	0.000191	0.00163	CcSEcCtD
Almotriptan—Pain—Doxorubicin—liver cancer	0.000189	0.00162	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—liver cancer	0.000189	0.00161	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—liver cancer	0.000189	0.00161	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—liver cancer	0.000182	0.00156	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000181	0.00155	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—liver cancer	0.000176	0.0015	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—liver cancer	0.000175	0.00149	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—liver cancer	0.000175	0.00149	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—liver cancer	0.000171	0.00147	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—liver cancer	0.000169	0.00145	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—liver cancer	0.000164	0.0014	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—liver cancer	0.000163	0.00139	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—liver cancer	0.000159	0.00136	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—liver cancer	0.000158	0.00135	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—liver cancer	0.000156	0.00134	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—liver cancer	0.000152	0.0013	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—liver cancer	0.000151	0.00129	CcSEcCtD
Almotriptan—Rash—Epirubicin—liver cancer	0.000151	0.00129	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—liver cancer	0.000151	0.00129	CcSEcCtD
Almotriptan—Headache—Epirubicin—liver cancer	0.00015	0.00128	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—liver cancer	0.000146	0.00125	CcSEcCtD
Almotriptan—Nausea—Epirubicin—liver cancer	0.000142	0.00121	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—liver cancer	0.000141	0.0012	CcSEcCtD
Almotriptan—Rash—Doxorubicin—liver cancer	0.000139	0.00119	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—liver cancer	0.000139	0.00119	CcSEcCtD
Almotriptan—Headache—Doxorubicin—liver cancer	0.000139	0.00118	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—liver cancer	0.000131	0.00112	CcSEcCtD
Almotriptan—CYP2C19—Metabolism—CRABP1—liver cancer	1.99e-05	0.000187	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARA—liver cancer	1.97e-05	0.000185	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GOT2—liver cancer	1.96e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HPGDS—liver cancer	1.95e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.94e-05	0.000182	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDOB—liver cancer	1.92e-05	0.00018	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—liver cancer	1.91e-05	0.00018	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TERT—liver cancer	1.91e-05	0.000179	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—liver cancer	1.87e-05	0.000176	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TERT—liver cancer	1.87e-05	0.000175	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CRABP1—liver cancer	1.83e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTA4—liver cancer	1.82e-05	0.000171	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.79e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.78e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTA2—liver cancer	1.78e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.77e-05	0.000166	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KDR—liver cancer	1.74e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.74e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HPGDS—liver cancer	1.74e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSMA4—liver cancer	1.74e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSMD10—liver cancer	1.74e-05	0.000163	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK14—liver cancer	1.73e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.73e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYCS—liver cancer	1.72e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTA1—liver cancer	1.72e-05	0.000161	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KDR—liver cancer	1.71e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—liver cancer	1.7e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK14—liver cancer	1.7e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NAT2—liver cancer	1.7e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GOT2—liver cancer	1.69e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GGT1—liver cancer	1.69e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GOT1—liver cancer	1.69e-05	0.000158	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CG—liver cancer	1.69e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—F2—liver cancer	1.68e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—liver cancer	1.66e-05	0.000156	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—liver cancer	1.65e-05	0.000155	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—F2—liver cancer	1.64e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.63e-05	0.000153	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—liver cancer	1.63e-05	0.000153	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDOB—liver cancer	1.63e-05	0.000153	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CPT1B—liver cancer	1.62e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GLUL—liver cancer	1.62e-05	0.000152	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APC—liver cancer	1.61e-05	0.000151	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CG—liver cancer	1.61e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HPGDS—liver cancer	1.6e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2E1—liver cancer	1.59e-05	0.000149	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.58e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APC—liver cancer	1.57e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CG—liver cancer	1.57e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NR1H4—liver cancer	1.57e-05	0.000147	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.56e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CRABP1—liver cancer	1.55e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSMD10—liver cancer	1.55e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSMA4—liver cancer	1.55e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTA3—liver cancer	1.54e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.54e-05	0.000144	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTP1—liver cancer	1.52e-05	0.000142	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—BRAF—liver cancer	1.51e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GOT2—liver cancer	1.51e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—liver cancer	1.5e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYCS—liver cancer	1.49e-05	0.00014	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CD—liver cancer	1.48e-05	0.000139	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—BRAF—liver cancer	1.48e-05	0.000139	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—liver cancer	1.46e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GGT1—liver cancer	1.46e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GOT1—liver cancer	1.46e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMA4—liver cancer	1.43e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMD10—liver cancer	1.43e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2E1—liver cancer	1.42e-05	0.000133	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CD—liver cancer	1.41e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTA4—liver cancer	1.41e-05	0.000132	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—liver cancer	1.4e-05	0.000131	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—liver cancer	1.4e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.4e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—liver cancer	1.39e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GOT2—liver cancer	1.39e-05	0.00013	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CD—liver cancer	1.38e-05	0.00013	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—liver cancer	1.38e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.37e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTA2—liver cancer	1.37e-05	0.000129	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—liver cancer	1.37e-05	0.000129	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—liver cancer	1.37e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HPGDS—liver cancer	1.36e-05	0.000127	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—liver cancer	1.35e-05	0.000127	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.35e-05	0.000127	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—liver cancer	1.35e-05	0.000126	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYCS—liver cancer	1.33e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTA1—liver cancer	1.32e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A1—liver cancer	1.32e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—liver cancer	1.31e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NAT2—liver cancer	1.31e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2E1—liver cancer	1.3e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GOT1—liver cancer	1.3e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GGT1—liver cancer	1.3e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—liver cancer	1.29e-05	0.000121	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CB—liver cancer	1.29e-05	0.000121	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—liver cancer	1.27e-05	0.000119	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RAF1—liver cancer	1.26e-05	0.000118	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDOB—liver cancer	1.25e-05	0.000118	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—liver cancer	1.24e-05	0.000117	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAF1—liver cancer	1.24e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—liver cancer	1.23e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—liver cancer	1.23e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—liver cancer	1.23e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.23e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYCS—liver cancer	1.22e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.21e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMA4—liver cancer	1.21e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMD10—liver cancer	1.21e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARA—liver cancer	1.21e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—liver cancer	1.21e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—liver cancer	1.21e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—liver cancer	1.2e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GGT1—liver cancer	1.2e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GOT1—liver cancer	1.2e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CRABP1—liver cancer	1.2e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—liver cancer	1.18e-05	0.00011	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GOT2—liver cancer	1.18e-05	0.00011	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—liver cancer	1.17e-05	0.00011	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—liver cancer	1.16e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—liver cancer	1.15e-05	0.000108	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—liver cancer	1.15e-05	0.000108	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—liver cancer	1.14e-05	0.000107	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—liver cancer	1.14e-05	0.000107	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—liver cancer	1.13e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—liver cancer	1.13e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—liver cancer	1.13e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—liver cancer	1.13e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—liver cancer	1.12e-05	0.000105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—liver cancer	1.11e-05	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—liver cancer	1.11e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2E1—liver cancer	1.11e-05	0.000104	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—liver cancer	1.1e-05	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—liver cancer	1.1e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—liver cancer	1.1e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—liver cancer	1.09e-05	0.000102	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—liver cancer	1.08e-05	0.000101	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—liver cancer	1.08e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—liver cancer	1.08e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—liver cancer	1.08e-05	0.000101	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—liver cancer	1.07e-05	0.0001	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.07e-05	0.0001	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—liver cancer	1.07e-05	0.0001	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—liver cancer	1.07e-05	0.0001	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—liver cancer	1.06e-05	9.99e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—liver cancer	1.06e-05	9.96e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—liver cancer	1.05e-05	9.84e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HPGDS—liver cancer	1.05e-05	9.82e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARA—liver cancer	1.04e-05	9.8e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—liver cancer	1.04e-05	9.8e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—liver cancer	1.04e-05	9.77e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—liver cancer	1.04e-05	9.75e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—liver cancer	1.03e-05	9.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYCS—liver cancer	1.03e-05	9.71e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—liver cancer	1.02e-05	9.57e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—liver cancer	1.02e-05	9.57e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—liver cancer	1.02e-05	9.54e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GGT1—liver cancer	1.01e-05	9.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GOT1—liver cancer	1.01e-05	9.53e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—liver cancer	9.99e-06	9.38e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—liver cancer	9.89e-06	9.28e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—liver cancer	9.61e-06	9.02e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—liver cancer	9.52e-06	8.93e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—liver cancer	9.5e-06	8.92e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—liver cancer	9.41e-06	8.84e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.38e-06	8.81e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—liver cancer	9.37e-06	8.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMD10—liver cancer	9.33e-06	8.76e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMA4—liver cancer	9.33e-06	8.76e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARA—liver cancer	9.32e-06	8.75e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—liver cancer	9.32e-06	8.75e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—liver cancer	9.12e-06	8.56e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—liver cancer	9.1e-06	8.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GOT2—liver cancer	9.07e-06	8.52e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—liver cancer	8.99e-06	8.44e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—liver cancer	8.98e-06	8.43e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—liver cancer	8.94e-06	8.4e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—liver cancer	8.84e-06	8.3e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—liver cancer	8.82e-06	8.28e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—liver cancer	8.74e-06	8.2e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—liver cancer	8.66e-06	8.13e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—liver cancer	8.64e-06	8.11e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—liver cancer	8.63e-06	8.1e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARA—liver cancer	8.57e-06	8.05e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2E1—liver cancer	8.53e-06	8.01e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—liver cancer	8.38e-06	7.86e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.37e-06	7.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—liver cancer	8.17e-06	7.67e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—liver cancer	8e-06	7.51e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—liver cancer	7.98e-06	7.49e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYCS—liver cancer	7.98e-06	7.49e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—liver cancer	7.94e-06	7.46e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—liver cancer	7.93e-06	7.44e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—liver cancer	7.88e-06	7.4e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—liver cancer	7.86e-06	7.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GGT1—liver cancer	7.83e-06	7.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GOT1—liver cancer	7.83e-06	7.35e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—liver cancer	7.76e-06	7.29e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—liver cancer	7.7e-06	7.23e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—liver cancer	7.51e-06	7.05e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—liver cancer	7.4e-06	6.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—liver cancer	7.35e-06	6.9e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—liver cancer	7.34e-06	6.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARA—liver cancer	7.26e-06	6.82e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—liver cancer	7.26e-06	6.82e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—liver cancer	7.11e-06	6.68e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—liver cancer	7.09e-06	6.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—liver cancer	7.04e-06	6.6e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—liver cancer	7.02e-06	6.59e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—liver cancer	6.95e-06	6.52e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—liver cancer	6.94e-06	6.51e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—liver cancer	6.93e-06	6.5e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—liver cancer	6.85e-06	6.43e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—liver cancer	6.8e-06	6.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—liver cancer	6.65e-06	6.24e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.52e-06	6.12e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—liver cancer	6.51e-06	6.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—liver cancer	6.46e-06	6.07e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—liver cancer	6.45e-06	6.06e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—liver cancer	6.44e-06	6.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—liver cancer	6.37e-06	5.98e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—liver cancer	6.22e-06	5.84e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—liver cancer	6.13e-06	5.76e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—liver cancer	6.13e-06	5.75e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—liver cancer	6.12e-06	5.74e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—liver cancer	6e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—liver cancer	6e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—liver cancer	5.71e-06	5.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—liver cancer	5.63e-06	5.28e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARA—liver cancer	5.61e-06	5.26e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—liver cancer	5.47e-06	5.13e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—liver cancer	5.4e-06	5.07e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—liver cancer	4.83e-06	4.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—liver cancer	4.8e-06	4.51e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—liver cancer	4.77e-06	4.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—liver cancer	4.63e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—liver cancer	4.22e-06	3.96e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—liver cancer	4.18e-06	3.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—liver cancer	4.17e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—liver cancer	3.95e-06	3.71e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—liver cancer	3.73e-06	3.5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—liver cancer	3.68e-06	3.45e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—liver cancer	3.43e-06	3.22e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—liver cancer	3.41e-06	3.2e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—liver cancer	3.05e-06	2.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—liver cancer	2.91e-06	2.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—liver cancer	2.8e-06	2.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—liver cancer	2.37e-06	2.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—liver cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—liver cancer	1.83e-06	1.72e-05	CbGpPWpGaD
